The Asia Pacific dialysis access treatment device market will continue to experience\u00a0modest\u00a0growth through 2032 after recovering from the impact of\u00a0COVID-19. The market will be primarily driven by rising adoption of innovative technologies such as percutaneous\u00a0AVF\u00a0for dialysis creation, and\u00a0DCBs for dialysis maintenance along with the favorable clinical trials results associated these devices. A significant rise in the expanding\u00a0ESRD\u00a0population will favor the market growth. However, revenue growth will be limited to some extent due to lack of reimbursement in the region leading to cost constraints, which in turn will hinder the adoption of the premium-priced devices.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for dialysis access treatment products in Asia Pacific from 2019 through 2032.<\/p>\n","protected":false},"template":"","class_list":["post-385764","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-geography-asia-pacific","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385764\/revisions"}],"predecessor-version":[{"id":387276,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385764\/revisions\/387276"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}